Timothy M. Kuzel, MD, FACP, discusses the use of immunotherapy as a targeted approach to treating cancer.
Timothy M. Kuzel, MD, FACP
Advertisement
Articles by Timothy M. Kuzel, MD, FACP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Sacituzumab Govitecan Monotherapy and In Combination With Pembrolizumab in Frontline TNBC
2
Daratumumab Retreatment Displays Activity in Relapsed Myeloma Following Continuous Frontline Therapy
3
Dr Tolaney on the FDA Approval of First-Line Sacituzumab Govitecan Plus Pembrolizumab for TNBC
4
QOL, Efficacy, and Cost Considerations Help Drive TKI Treatment Selection in CML
5